Kaltura (NASDAQ:KLTR – Get Free Report) had its price objective raised by stock analysts at Wells Fargo & Company from $1.00 to $1.50 in a note issued to investors on Thursday, Benzinga reports. The firm currently has an “underweight” rating on the stock. Wells Fargo & Company‘s price objective would suggest a potential downside of […]

Itron (NASDAQ:ITRI – Free Report) had its target price boosted by Guggenheim from $128.00 to $135.00 in a report issued on Wednesday, Benzinga reports. They currently have a buy rating on the scientific and technical instruments company’s stock. A number of other equities research analysts also recently issued reports on ITRI. Roth Mkm boosted their […]

Qualys (NASDAQ:QLYS – Free Report) had its price target lifted by Canaccord Genuity Group from $160.00 to $170.00 in a research note issued to investors on Wednesday, Benzinga reports. They currently have a buy rating on the software maker’s stock. Other analysts have also issued research reports about the stock. Scotiabank reduced their price target […]

Progressive (NYSE:PGR – Get Free Report) had its price target lifted by analysts at Evercore ISI from $277.00 to $285.00 in a research report issued on Wednesday, Benzinga reports. The brokerage currently has an “outperform” rating on the insurance provider’s stock. Evercore ISI’s price target points to a potential upside of 12.02% from the company’s […]

Marriott International (NASDAQ:MAR – Free Report) had its price target increased by BMO Capital Markets from $255.00 to $265.00 in a report published on Tuesday, Benzinga reports. BMO Capital Markets currently has a market perform rating on the stock. MAR has been the subject of a number of other reports. Bank of America upped their […]

Hologic (NASDAQ:HOLX – Free Report) had its price objective hoisted by UBS Group from $84.00 to $90.00 in a research report report published on Tuesday morning, Benzinga reports. They currently have a neutral rating on the medical equipment provider’s stock. Other research analysts have also recently issued research reports about the company. Evercore ISI boosted […]

Astera Labs (NASDAQ:ALAB – Free Report) had its price objective hoisted by Roth Mkm from $80.00 to $105.00 in a research note published on Tuesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. A number of other equities research analysts have also recently commented on ALAB. Stifel Nicolaus raised their […]